Geoffrey OBrien - 09 Jan 2024 Form 4 Insider Report for MEDICINOVA INC (MNOV)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MNOV	Employee Stock Option (Right to Buy)	Award	$0	+84,000		$0.000000	84,000	09 Jan 2024	Common Stock	84,000	$2.40	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	On February 1, 2023 the reporting person was granted an option to purchase 120,000 shares of common stock. The option vests based on the satisfaction of certain performance criteria for the fiscal year ended December 31, 2023. Such performance criteria for 2023 were achieved at the 70% attainment level, resulting in vesting of the option as to 84,000 shares.